上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1422Please respect copyright.PENANAgpTQacIwOc
1422Please respect copyright.PENANAxqZc934Bz4
上集:https://www.penana.com/article/4711251422Please respect copyright.PENANAZ0PFXznlUf
1422Please respect copyright.PENANAQCvsEL69Y41422Please respect copyright.PENANA39YvLNrSmH
1422Please respect copyright.PENANAK30viWq42T
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1422Please respect copyright.PENANAG3EctqAu5w
1422Please respect copyright.PENANAFzfwBszANf
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1422Please respect copyright.PENANAh28RppsNqZ
1422Please respect copyright.PENANAuQZ3VPChPO
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1422Please respect copyright.PENANA4RZUCm5xwb
1422Please respect copyright.PENANAGHTUDtvbsc1422Please respect copyright.PENANA0YfQazcC2r
1422Please respect copyright.PENANAsDQC4FC6YO
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1422Please respect copyright.PENANALCLMX92iWa
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1422Please respect copyright.PENANAO0ysXUbkqy
1422Please respect copyright.PENANANcEsgopaKM
忘記甚麼是Neoantigen的話,可重溫上一集。1422Please respect copyright.PENANAEahkRhhqKI
1422Please respect copyright.PENANAKGKVtnZ4CV
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1422Please respect copyright.PENANAtkpTDCXeiC
1422Please respect copyright.PENANAphZdQwZjJc
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1422Please respect copyright.PENANAPzG8LBkmGf
1422Please respect copyright.PENANAP93Q2H7rRI1422Please respect copyright.PENANAbYLn1lqIgh
1422Please respect copyright.PENANA1zIfzAa4tT
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1422Please respect copyright.PENANACJ3rlgbONY
1422Please respect copyright.PENANAS99zLcn2kM
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1422Please respect copyright.PENANACgatiIVN5m
1422Please respect copyright.PENANAFAwxTZuVi1
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1422Please respect copyright.PENANA5nVPjsO8Vp1422Please respect copyright.PENANALlhqiVixMy
1422Please respect copyright.PENANAl7sGpe4Kt7
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1422Please respect copyright.PENANAFXUDGKONMo
1422Please respect copyright.PENANAdIH4Ua1FA0
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1422Please respect copyright.PENANAXxblFRF5BH1422Please respect copyright.PENANAehoXAknghM
1422Please respect copyright.PENANAITQugW44EU
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1422Please respect copyright.PENANAiAlA5UH99y
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1422Please respect copyright.PENANANvTuwEYOPD
1422Please respect copyright.PENANAQAYkfW4wnV
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1422Please respect copyright.PENANAYUkUKsFhoa
1422Please respect copyright.PENANAf4N2ayZfO9
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1422Please respect copyright.PENANAL2Pvzqb6n9
1422Please respect copyright.PENANAkjL9chRCKj
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1422Please respect copyright.PENANAJb4SJ2cEje
1422Please respect copyright.PENANAfRGQR6ze76
1422Please respect copyright.PENANAsDooiKjzRK
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1422Please respect copyright.PENANAxGIX1jgsCw
1422Please respect copyright.PENANAdUcvrGXxn9
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1422Please respect copyright.PENANA2VpP4RwhAn
1422Please respect copyright.PENANAuHWkthvMAb
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1422Please respect copyright.PENANAcxaruglqk1
1422Please respect copyright.PENANAwhP8rUCOIA
Link:1422Please respect copyright.PENANAaSdAgsIys6
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1422Please respect copyright.PENANAsr08mcNOx9
1422Please respect copyright.PENANAs0zQMy4luU
1422Please respect copyright.PENANAy5ARbRb6Iq
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1422Please respect copyright.PENANAGwEtKLs0Ga